Long-Term Liabilities: The sum of all non-current liabilities.
Relay Therapeutics, Inc. (RLAY) had Long-Term Liabilities of $26.64M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.35M |
|
$-83.71M |
|
-- |
|
$0.35M |
|
$91.17M |
|
$-90.82M |
|
$7.12M |
|
$-83.71M |
|
$-83.71M |
|
$-83.71M |
|
$-83.71M |
|
$-83.71M |
|
$-83.71M |
|
$-90.82M |
|
$-91.09M |
|
202.85M |
|
202.85M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$928.08M |
|
$0.86M |
|
$39.38M |
|
$967.46M |
|
$50.80M |
|
-- |
|
|
Long-Term Liabilities |
$26.64M |
$77.45M |
|
$890.01M |
|
$890.01M |
|
$890.01M |
|
218.53M |
|
| Cash Flow Statement Financials | |
$-105.22M |
|
$-320.12M |
|
$462.52M |
|
$85.35M |
|
$122.53M |
|
$37.17M |
|
$19.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-25949.72% |
|
-25949.72% |
|
-- |
|
-23916.29% |
|
-23916.29% |
|
$-105.22M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-9.41% |
|
-9.41% |
|
-8.65% |
|
-9.41% |
|
$4.07 |
|
$-0.52 |
|
$-0.52 |
|